Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

NCT: NCT05903950 · RECRUITING

NCT IDNCT05903950
StatusRECRUITING
Start Date2024-11-03
Completion2026-12
SponsorWeill Cornell Medical College in Qatar (OTHER)
First posted
Last updated

Brief Summary

The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.

Frequently Asked Questions

What is Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure?

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure is a clinical trial registered under NCT05903950. Current status: RECRUITING.

What is the status of NCT05903950?

The current status of NCT05903950 (Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure) is: RECRUITING.

When did Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure start?

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure started on 2024-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑